1. AAFS Standards Board 2019. Standard Practices for Method Validation in Forensic Toxicology. American Academy of Forensic Sciences, http://www.asbstandardsboard.org/wp-content/uploads/2019/11/036_Std_e1.pdf.
2. Barceloux, D. G. (2012). Lysergic acid diethylamide (LSD). (In) D. G. Barceloux, Medical toxicology of drug abuse: synthesized chemicals and psychoactive plants (pp. 452–466). Wiley.
3. Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Stratford, A., Nichols, D. E., Halberstadt, A. L. (2017). Return of the lysergamides. Part III : Analytical characterization of N6-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1 propionyl ETH-LAD (1P–ETHLAD). Drug Testing and Analysis, 9(10), 1641–1649. DOI : 10.1002/dta.2196.
4. Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., Wallach, J., Halberstadt, A. L. (2019). Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Drug Testing and Analysis, 11(8), 1122–1133. DOI : 10.1002/dta.2613.
5. Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Hoang, K., Wallach, J., Halberstadt, A. L. (2016). Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Testing and Analysis, 8(9), 891–902. DOI : 10.1002/dta.1884.
6. Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Odland, A. U., Klein, A. K., Dowling, G., Dempster, N. M., Wallach, J., Passie, T., Halberstadt, A. L. (2020). Return of the lysergamides. Part VI: Analytical  and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Testing and Analysis, 12(6), 812–826. DOI : 10.1002/dta.2789.
7. Elliott, S. P., Holdbrook, T., Brandt, S. D. (2020). Prodrugs of new psychoactive substances (NPS): A new challenge. Journal of Forensic Sciences, 65(3), 913–920. DOI : 10.1111/1556-4029.14268.
8. Grumann, C., Henkel, K., Brandt, S. D., Stratford, A., Passie, T., Auwärter, V. (2020). Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration. Drug Testing and Analysis, 12(8), 1144–1153. DOI : 10.1002/dta.2821.
9. Grumann, C., Henkel, K., Stratford, A., Hermanns-Clausen, M., Passie, T., Brandt, S. D., Auwärter, V. (2019). Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions. Journal of Pharmaceutical and Biomedical Analysis, 174, 270–276. DOI : 10.1016/j.jpba.2019.05.062.
10. Halberstadt, A. L., Chatha, M., Klein, A. K., McCorvy, J. D., Meyer, M. R., Wagmann, L., Stratford, A., Brandt, S. D. (2019). Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology, 172, 107856. DOI : 10.1016/j.neuropharm.2019.107856.
11. Halberstadt, A. L., Geyer, M. A. (2013). Neuropharmacology of lysergic acid diethylamide (LSD) and other hallucinogens. (In) P. M. Miller (Ed.), Biological research on addiction (pp. 625–635). Academic Press.
12. Liester, M. B. (2014) A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects. Current Drug Abuse Reviews, 7(3), 146–156. DOI : 10.2174/1874473708666150107120522.
13. Molina, D. K. (2010). Handbook of forensic toxicology for medical examiners. Boca Raton: CRC Press. 
14. Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14(4), 295–314. DOI : 10.1111/j.1755-5949.2008.00059.x.
15. Wagmann, L., Richter, L. H. J., Kehl, T., Wack, F., Bergstrand, M. P., Brandt, S. D., Stratfor, A., Maurer, H. H., Meyer, M. R. (2019). In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Analytical and Bioanalytical Chemistry, 411(19), 4751–4763. DOI : 10.1007/s00216-018-1558-9.